Blog
RSS FeedPosted by Michael Wonder on 30 Nov 2016
NICE says people with osteoporosis should be assessed for their fracture risk
30 November 2016 - People at risk of fractures due to osteoporosis should be considered for medication, NICE says. ...
Posted by Michael Wonder on 30 Nov 2016
New Zealand Pharmaceutical Schedule - 1 December 2016
1 December 2016 - The December 2016 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 30 Nov 2016
Pharmacies need 6CPA risk share
30 November 2016 - The reason why the Federal Government and community pharmacies have entered into six successive agreements for ...
Posted by Michael Wonder on 30 Nov 2016
South Australia to commence PrEP trials
30 November 2016 - The South Australian Premier Jay Wetherill has announced people at high risk of contracting HIV will ...
Posted by Michael Wonder on 29 Nov 2016
NICE recommends 4p a day breast cancer drug
29 November 2016 - Women with a family history of breast cancer should be offered anastrozole, not tamoxifen, says NICE ...
Posted by Michael Wonder on 28 Nov 2016
Utilisation and cost model workbook to accompany PBAC Guidelines
29 November 2016 - A utilisation and cost model workbook has been developed to accompany the Pharmaceutical Benefit Advisory Committee ...
Posted by Michael Wonder on 28 Nov 2016
Pfizer fears rough ride with NICE over breast cancer drug
28 November 2016 - Pfizer’s Ibrance breast cancer pill may have been a huge hit in the US, where it ...
Posted by Michael Wonder on 27 Nov 2016
Pressure on meningococcal vaccine for WA
27 November 2016 - An increase in W strain meningococcal cases in Western Australia has prompted state Health Minister John ...
Posted by Michael Wonder on 25 Nov 2016
NICE reverses decision on CDF leukaemia drug after price drop
25 November 2016 - Hundreds of people could benefit as NICE decision means ibrutinib can come off the Cancer Drugs Fund ...
Posted by Michael Wonder on 25 Nov 2016
Drug prices threaten the NHS
7 November 2016 - The recent Lancet Editorial on the High Court ruling that rejected NHS England's decision not to ...
Posted by Michael Wonder on 25 Nov 2016
CADTH calls for input on submission for new medicine for patients with biliary cirrhosis
24 November 2016 - CADTH is calling for patient input on a pending submission from Intercept Pharmaceuticals for obeticholic acid. ...
Posted by Michael Wonder on 25 Nov 2016
Agenda for 30 November 2016 TC meeting
24 November 2016 - HAS has posted the agenda for the next scheduled TC meeting. ...
Posted by Michael Wonder on 24 Nov 2016
CADTH issues second final recommendation for Ibrance (palbociclib)
21 November 2016 - CADTH has published a final outcome for palbociclib following a resubmission from Pfizer. ...
Posted by Michael Wonder on 24 Nov 2016
Pancreatic cancer: new treatment could see advanced patients live twice as long
24 November 2016 - Advanced pancreatic cancer patients in Scotland may benefit from a new treatment which could allow them to ...
Posted by Michael Wonder on 24 Nov 2016
Petition to pressure PHARMAC over HIV meds
24 November 2016 - Three years after a irrefutable case was made by HIV organisations and specialists the NZAF is reporting ...